Dr Feldman on the Background of the TRANSCEND CLL 004 Trial in CLL/SLL
Tatyana Feldman, MD, discusses the launch of the TRANSCEND CLL 004 trial in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Source: onclive.com
Page 32 - Cll News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cll Today - Breaking & Trending Today
SOC Drugs Provide Strong Foundation For Effective Combinations in Hematologic Malignancies
Catherine C. Coombs, MD, discusses future directions for BTK inhibitors in chronic lymphocytic leukemia and combination therapies in myelofibrosis.
Source: onclive.com
Dr Ann LaCasce Discusses Potentially Game Changing Treatments for Lymphoma
Ann LaCasce, MD, MMSc, director of the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology and chair of the Lymphoma Research Foundation’s scientific advisory board, discussed the changing lymphoma treatment landscape and highlighted potentially game changing treatments.
Source: ajmc.com
Dr Coombs on Notable BTK Inhibitor Combination Studies in CLL
Callie Coombs, MD, discusses the investigation of notable BTK inhibitor combination trials in patients with chronic lymphocytic leukemia.
Source: onclive.com
Emerging Data Surrounding Mechanisms of Resistance to Non-Covalent BTKis
The expert panel discusses recent data regarding the mechanisms of resistance to non-covalent BTK inhibitors in CLL.
Source: onclive.com